A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Clinical trial NCT01194570 · COMPLETED

Trial details

NCT number: NCT01194570
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Primary Progressive

Start date: 2011-03-02
Primary completion: 2015-07-23
Enrollment: 735

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.